ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
iShares Biotechnology ETF

iShares Biotechnology ETF (IBB)

142.7302
-0.2698
( -0.19% )
Updated: 13:36:31

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
142.7302
Bid
142.73
Ask
142.75
Volume
666,376
142.31 Day's Range 143.47
111.83 52 Week Range 150.565
Market Cap
Previous Close
143.00
Open
142.82
Last Trade
8
@
142.75
Last Trade Time
13:35:55
Financial Volume
US$ 95,302,137
VWAP
143.0156
Average Volume (3m)
1,153,060
Shares Outstanding
55,600,000
Dividend Yield
-
PE Ratio
25.43
Earnings Per Share (EPS)
5.62
Revenue
52.52M
Net Profit
312.5M

About iShares Biotechnology ETF

The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies... The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc., including minimum market capitalization and liquidity requirements. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
iShares Biotechnology ETF is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker IBB. The last closing price for iShares Biotechnology ETF was US$143. Over the last year, iShares Biotechnology ETF shares have traded in a share price range of US$ 111.83 to US$ 150.565.

iShares Biotechnology ETF currently has 55,600,000 shares outstanding. The market capitalization of iShares Biotechnology ETF is US$7.95 billion. iShares Biotechnology ETF has a price to earnings ratio (PE ratio) of 25.43.

IBB Latest News

Tarsus Added to NASDAQ Biotechnology Index

IRVINE, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...

Aquestive Therapeutics Added to NASDAQ Biotechnology Index

WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products...

BlackRock Announces Product Updates to Two iShares ETFs

BlackRock, Inc. (NYSE: BLK) today announced product enhancements to two iShares ETFs as part of an ongoing process to periodically review its product lineup. No action is necessary for investors...

MediciNova Added to the NASDAQ Biotechnology Index

LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock...

Scholar Rock Added to NASDAQ Biotechnology Index

CAMBRIDGE, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in...

BioDelivery Sciences Added to NASDAQ Biotechnology Index

RALEIGH, N.C., Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to...

Mirati Therapeutics Added To NASDAQ Biotechnology Index

Mirati Therapeutics Added To NASDAQ Biotechnology Index PR Newswire SAN DIEGO, Dec. 20, 2018 SAN DIEGO, Dec. 20, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage...

Strongbridge Biopharma plc Added to the NASDAQ Biotech Index

DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development...

BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF

BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB). The Board has approved a 3-for-1...

MARKET SNAPSHOT: Dow Makes A Run At Elusive 20,000 Amid Earnings Fusillade

By Anora Mahmudova and Mark DeCambre, MarketWatch S&P 500, Nasdaq Composite on track to mark closing records U.S. stocks swung higher Tuesday, with the Dow Jones Industrial Average making...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.7498-0.522581544466143.48145.0751141.695732267143.23098492SP
4-1.7198-1.1905849775144.45150.565141.6951086456145.83389967SP
12-4.6398-3.14840198141147.37150.565137.691153060145.28125915SP
269.62027.22725565322133.11150.565123.61302783138.70494943SP
5221.180217.4250925545121.55150.565111.831596766133.06859814SP
156-12.2898-7.92788027351155.02164.83104.291863415130.73914311SP
26044.550245.376044000898.18177.3792.152346848135.17203535SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
USAAmericas Gold and Silver Corporation
$ 0.53
(21.84%)
1.28M
SFDNXT Energy Solutions Inc
$ 0.25
(19.05%)
540
BRBig Rock Brewery Inc
$ 1.28
(14.29%)
800
GVCGlacier Media Inc
$ 0.13
(13.04%)
127k
DIAMStar Diamond Corporation
$ 0.045
(12.50%)
283k
AXISAxis Auto Finance Inc
$ 0.01
(-33.33%)
2.7k
NCFNorthcliff Resources Ltd
$ 0.02
(-20.00%)
267.9k
SAMStarcore International Mines Ltd
$ 0.145
(-12.12%)
42.2k
GRCGold Springs Resource Corp
$ 0.075
(-11.76%)
12.5k
CRDLCardiol Therapeutics Inc
$ 2.38
(-11.52%)
688.43k
BTEBaytex Energy Corp
$ 4.35
(-1.14%)
3.64M
GLOGlobal Atomic Corporation
$ 1.10
(0.92%)
2.87M
VRNVeren Inc
$ 8.86
(-0.78%)
2.58M
CNQCanadian Natural Resources Ltd
$ 49.91
(0.60%)
1.91M
CVECenovus Energy Inc
$ 23.97
(-0.66%)
1.71M

IBB Discussion

View Posts
Traderprofessional1 Traderprofessional1 4 years ago
INVVY will Dip and all to $3.00 by end of day unfortunately, the NEXT BIG RUNNER Will Be TNNP)
👍️0
Traderprofessional1 Traderprofessional1 4 years ago
#STOCKS #StockMarket #biotech #LABU #StockMarketCrash20 #STOCKSTOBUY #stockmarkets #STOCKCRASH Unfortunately ?? The STOCKS will Crash, the Markets will get Totally Blood Red ,SELL THIS IS UR FINAL WARNING OR LOSE ALL UR $$$$ ?? MONEY!!! Only 1 ETF u will make $$ is on #LABD
👍️0
nowwhat2 nowwhat2 5 years ago








👍️0
ITMS ITMS 7 years ago
Price Target On The NASDAQ BioTech ETF Revealed

As certain market sectors stall out, the biotechnology sector burst through its 2017 highs. This breakout will trigger a continued squeeze even higher on the iShares NASDAQ BioTech ETF $IBB. At a current price of $118.81, investors should expect further upside to a $133.00 target in the next month. Once there, investors should expect a sharp pull back and potential high for 2018. As a swing trader, I am patiently waiting to short that pivot high at $133.00 for a pull back to $114.50.





Gareth Soloway
InTheMoneyStocks
👍️0
ciciagt ciciagt 7 years ago
3:1 share split effective

BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB).

The Board has approved a 3-for-1 split for the fund for shareholders of record as of the close of business on November 28, 2017, payable after the close of trading on November 30, 2017. The 3-for-1 split will lower the share price and increase the number of outstanding shares. The total value of shares outstanding is not affected by the split.

👍️0
ash111 ash111 7 years ago
IBB on fire, here why: FDA Approves Futuristic New Cancer Therapy, To Cost $475,000, Sending Biotechs Surging http://www.zerohedge.com/news/2017-08-30/fda-approves-futuristic-new-cancer-drug-cost-475000-sending-biotechs-surging
👍️0
Twister Twister 7 years ago
FINALLY... It breaks out; for now anyway!
👍️0
floored floored 7 years ago
Actually the answer is Obama care is working with the participating according to the latest Yahoo Finance report. This means more uncertainty in the future and an uphill battle to repeal. This could go on for quite a while longer but like always, the health care trend is upwards in the long run.
👍️0
MiguelHammond10 MiguelHammond10 7 years ago
Since more people R covered under Obamacare , would that be good for bio since bio was strong for yrs under Obama until election.
👍️0
TREND1 TREND1 7 years ago
IBB LONG TERM is UP

👍️0
chriswolff chriswolff 7 years ago
See if the IBB can rip a little higher tomorrow. SPY watch volume very important in these complacent markets. imo Save the QQQ.
👍️0
jones99 jones99 7 years ago
Nothing goes straight up. I am bullish on biotech but I expect some profit taking soon. Would be a buyer on any pullback.
👍️0
BlueAlien BlueAlien 7 years ago
Looks like Merck is leading the pack here

ARRY - speculative cancer company running
👍️0
nowwhat2 nowwhat2 7 years ago
300 Breakout

👍️0
joe_techi joe_techi 8 years ago
Closed over $300. Welcome back!
👍️0
leyva leyva 8 years ago
2017 will be a record year for the IBB
👍️0
annabelletrader annabelletrader 8 years ago
It is pretty crazy to think a stock chart can predict an event but the biotechnology ETF $IBB looks to have done just that. Yesterday, the ETF that tracks biotechnology and pharma stocks slammed into a trend line that is found by connecting the recent highs (see the chart below). Any technical trader will tell you that a sharp pull back should occur. Out walked Donald Trump today to give his press conference. One of the first things he did is trash biotech/pharma stocks over drug prices. The $IBB (biotech ETF) collapsed.



The stock chart here predicted the price action perfectly. However, most investors ignore the stock charts and trade off of CNBC and other media hype. Start watching the stock charts and become a better trader.





The biotech ETF stock chart predicted the Donald Trump slam
👍️0
kingsransome kingsransome 8 years ago
why is not algo-rythem trading outlawed,its doing more harm than good for stable markets
👍️0
catty catty 8 years ago
Am looking to get back into IBB because the group willprobably bounce back strong with Trump's support of the industry. (unlike Hillary). Am watching and waiting until the dust settles.
👍️0
Panzer Panzer 8 years ago
Looks to be capitulation now or soon
👍️0
ShotMaker ShotMaker 8 years ago
IF this can hold support around $240...it might flip back for a nice short run, for those willing to take a chance on it. I am watching it closely.
👍️0
kingsransome kingsransome 8 years ago
luv to see hillarys tweets backfire on her lying azz,,,ibb $300+ soon
👍️0
kingsransome kingsransome 8 years ago
hillary again opens her corrupt mouth and crash,,this has gotten old,,such a joke this game is.wish i had funds to buy
👍️0
jones99 jones99 8 years ago
This looked healthy yesterday. All about getting through $300-$303.
👍️0
kingsransome kingsransome 8 years ago
nice call huh,,shrts r f'ed $$$$
👍️0
kingsransome kingsransome 8 years ago
here we go,,scare tactic worked for shorts to cover a bit,now we break for $300 trend,,myop $$$$
👍️0
TREND1 TREND1 8 years ago
***** IBB 1 HOUR CLOSES

👍️0
TREND1 TREND1 8 years ago
***** IBB MONTHLY 3 LINE BREAK

👍️0
TREND1 TREND1 8 years ago
***** IBB MONTHLY



👍️0
TREND1 TREND1 8 years ago
***** IBB DAY

👍️0
ITMS ITMS 8 years ago
This Is A Major Concern For Investors $IBB

The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has bounced beautifully off of double bottom support at $240 on the daily chart. Today it traded as high as $254.70, just two days after hitting $240.00.

Investors are wondering if it is safe to buy the $IBB? The short answer is... no. This is why...

There is a major concern on the daily chart of the biotech ETF IBB. Notice the confirmed break down that took place when the IBB broke through the upsloping trend line. Once confirmed, a retrace into that trend line (like we are seeing today) is almost always a heavy shorting opportunity. That means the IBB may fall sharply as early as next week. If the IBB is falling hard, you can bet the market is dropping sharply. This should be a major concern to not only biotech investors but all investors in the stock market. Note the chart below...

Chart: https://verifiedinvesting.com/uploads/files/IBB06.29.2016.JPG

👍️0
nowwhat2 nowwhat2 8 years ago
Risk ON !....Risk ON !....




👍️0
Pro-Life Pro-Life 8 years ago
This sector, along with banking and others, is collapsing.
👍️0
nowwhat2 nowwhat2 8 years ago
Our beloved IBB :

👍️0
catty catty 8 years ago
We're starting to look good again.
👍️0
catty catty 8 years ago
rusty: typo error: Meant $4.00
👍️0
dannyzee84 dannyzee84 8 years ago
Gogogo push past 287 into 288 lets get to 290 before 3
👍️0
dannyzee84 dannyzee84 8 years ago
Now 290 before 3pm!! Go IBB
👍️0
dannyzee84 dannyzee84 8 years ago
Show me the a green day before 230!!
👍️0
dannyzee84 dannyzee84 8 years ago
Go for greeeeen!!!
👍️0
dannyzee84 dannyzee84 8 years ago
A lot of selling going on today.. Surprising it looked like it was going to breakout past 290 resistance
👍️0
dannyzee84 dannyzee84 8 years ago
Would like to see this push back to green on the day before 1pm
👍️0
catty catty 8 years ago
rusty: Just $400 to go
👍️0
dannyzee84 dannyzee84 8 years ago
Sweet move under 285
👍️0
rusty8350 rusty8350 8 years ago
Let's just see it close above 290 this week. It's ready to. Best of luck
👍️0
catty catty 8 years ago
rusty: hope so...would like to see it hit $300 and then some! Seems we're the only two on the board paying attention
👍️0
rusty8350 rusty8350 8 years ago
I think biotechs are getting ready to move. DOW hitting new highs..... many large biotechs reporting good earnings and forecasts.
👍️0
catty catty 9 years ago
River: Agreed
👍️0
nowwhat2 nowwhat2 9 years ago
Well Nasdaq 5000 is not far away and....

How are the Bio-techs doing ?

👍️0
RiverNorth RiverNorth 9 years ago
This will get over $400 imo
👍️0

Your Recent History

Delayed Upgrade Clock